Full data view for gene BRCA2

All records describing functional studies of specific variants.
BRCA2 variants classified by the ENIGMA consortium.
Variants associated with Fanconi anemia
A Fanconi anemia mutation database.
Information The variants shown are described using the NM_000059.3 transcript reference sequence.

14 entries on 1 page. Showing entries 1 - 14.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

Haplotype     

Allele     

Classification method     

Clinical classification     

DNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Template     

Technique     

Tissue     

Remarks     

Disease     

ID_report     

Reference     

Remarks     

Gender     

Consanguinity     

Country     

Population     

Age at death     

VIP     

Data_av     

Treatment     

Panel size     

Owner     
+/+ 7 c.631G>A r.(spl?) p.(?) - Unknown - pathogenic g.32900750G>A g.32326613G>A - - BRCA2_000040 - - - - Unknown ? - - - - DNA SEQ ? - cancer, breast - - - - ? Netherlands - - - - - 1 Hans Gille
+/. 7 c.631G>A r.spl p.Val211Ile - Unknown - NA g.32900750G>A g.32326613G>A V211I - BRCA2_000040 mRNA analysis (RT-PCR); predicted deleterious PubMed: Colombo 2009 - - In vitro (cloned) - - - - - - - - - - - - - - - - - - - - - - -
+?/. 7 c.631G>A r.spl p.Val211Ile - Unknown - NA g.32900750G>A g.32326613G>A c.631G>A - BRCA2_000040 splicing reporter minigene; major exon skipping PubMed: Gaildrat 2012 - - In vitro (cloned) - - - - - - - - - - - - - - - - - - - - - - -
+/. 7 c.631G>A r.spl p.Val211Ile - Unknown - NA g.32900750G>A g.32326613G>A V211I - BRCA2_000040 cDNA analysis; predicted deleterious PubMed: Pensabene 2009 - - In vitro (cloned) - - - - - - - - - - - - - - - - - - - - - - -
-/. 7 c.631G>A r.(?) p.Val211Ile - Unknown - NA g.32900750G>A g.32326613G>A V211I - BRCA2_000040 Radiation sensitivity; as wildtype control PubMed: Pensabene 2009 - - In vitro (cloned) - - - - - - - - - - - - - - - - - - - - - - -
+/. 7 c.631G>A r.(?) p.(Val211Ile) - Parent #1 - pathogenic g.32900750G>A g.32326613G>A - - BRCA2_000040 - PubMed: Rebbeck 2018, Journal: Rebbeck 2018 - - Germline - - - - - DNA SEQ - - cancer, breast CIMBA-Fam? PubMed: Rebbeck 2018, Journal: Rebbeck 2018 4 families F - Italy white - - - - 4 Johan den Dunnen
+/. 7 c.631G>A r.(?) p.(Val211Ile) - Parent #1 - pathogenic g.32900750G>A g.32326613G>A - - BRCA2_000040 - PubMed: Rebbeck 2018, Journal: Rebbeck 2018 - - Germline - - - - - DNA SEQ - - cancer, breast CIMBA-Fam? PubMed: Rebbeck 2018, Journal: Rebbeck 2018 3 families F - United States white - - - - 3 Johan den Dunnen
?/. - c.631G>A r.(?) p.(Val211Ile) - Parent #1 - VUS g.32900750G>A g.32326613G>A - - BRCA2_000040 classified as class 3, 4 or 5 in 1/25800 full screen tests: PHE release 2 BRCA germline variants (June 19, 2019). Entry from British diagnostic laboratories uploaded via Public Health England. Where benign/likely benign variants were excluded. Currently variants are classified as either "3, 4 or 5" or "1, 2, 3, 4 or 5". UK Variant Sharing Initiative - - CLASSIFICATION record - 1 case - - - DNA SEQ - - BROVCA - UK Variant Sharing Initiative analysis breast/ovarian cancer cases - - United Kingdom (Great Britain) - - - - - 1 UK Variant Sharing Initiative
+/. 7 c.631G>A r.(?) p.(Val211Ile) - Parent #1 - pathogenic (dominant) g.32900750G>A g.32326613G>A - - BRCA2_000040 - PubMed: Santonocito 2020 - rs80358871 Germline - 4/2351 cases - - - DNA SEQ-NG - BRCA1/2 sequencing BROVCA ? PubMed: Santonocito 2020 analysis 2351 breast/ovarian cancer patients - - Italy - - - - - 4 Johan den Dunnen
+/. - c.631G>A r.(?) p.(Val211Ile) - Unknown - pathogenic (dominant) g.32900750G>A g.32326613G>A - - BRCA2_000040 - PubMed: Santonocito 2020 - rs80358871 Germline - 1/2351 cases - - - DNA SEQ-NG - BRCA1/2 sequencing BROVCA Pat13 PubMed: Santonocito 2020 analysis 2351 breast/ovarian cancer patients - - Italy - - - - - 1 Johan den Dunnen
+/. - c.631G>A r.(?) p.(Val211Ile) - Unknown - pathogenic (dominant) g.32900750G>A g.32326613G>A - - BRCA2_000040 - PubMed: Santonocito 2020 - rs80358871 Germline - 1/2351 cases - - - DNA SEQ-NG - BRCA1/2 sequencing BROVCA Pat25 PubMed: Santonocito 2020 analysis 2351 breast/ovarian cancer patients - - Italy - - - - - 1 Johan den Dunnen
+/. - c.631G>A r.(?) p.(Val211Ile) - Unknown - pathogenic (dominant) g.32900750G>A g.32326613G>A - - BRCA2_000040 - PubMed: Santonocito 2020 - rs80358871 Germline - 1/2351 cases - - - DNA SEQ-NG - BRCA1/2 sequencing BROVCA Pat26 PubMed: Santonocito 2020 analysis 2351 breast/ovarian cancer patients - - Italy - - - - - 1 Johan den Dunnen
+/. - c.631G>A r.(?) p.(Val211Ile) - Unknown - pathogenic (dominant) g.32900750G>A g.32326613G>A - - BRCA2_000040 - PubMed: Santonocito 2020 - rs80358871 Germline - 1/2351 cases - - - DNA SEQ-NG - BRCA1/2 sequencing BROVCA Pat9 PubMed: Santonocito 2020 analysis 2351 breast/ovarian cancer patients - - Italy - - - - - 1 Johan den Dunnen
?/. - c.631G>A r.(?) p.(Val211Ile) - Parent #1 - NA g.32900750G>A - chr13_32900750_G_A - BRCA2_000040 not in 60466 cases; the study was not designed to clinically classify individual variants but performed burden-type association analyses, grouping certain variant types PubMed: Dorling 2021, Journal: Dorling 2021 - - Germline - 1/53461 controls - - - DNA SEQ-NG - 34-gene panel Healthy/Control - PubMed: Dorling 2021, Journal: Dorling 2021 analysis 53461 controls (BRIDGES) - - - - - - bcac.ccge.medschl.cam.ac.uk/contact - 1 BRIDGES consortium
Legend   How to query  


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.